SCHEMBL3750573

SCHEMBL3750573

COC1=C(OC)C(=O)C(C=C(C)C(=O)O)=C(Cl)C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 17/20 1.00
AKR1C3 P42330 1/20 0.39
KDM4E B2RXH2 1/20 0.32
S1PR4 O95977 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MAPT P10636 1/20 0.32
G6PD P11413 1/20 0.32
S1PR1 P21453 1/20 0.32
MAPK1 P28482 1/20 0.32
OPRK1 P41145 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
MCL1 Q07820 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
TLR9 Q9NR96 1/20 0.32
CMA1 P23946 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3750568 1.00 APEX1 (1.00) APEX1AKR1C3KDM4ES1PR4HSP90AA1
SCHEMBL3755956 0.81 APEX1 (1.00) APEX1AKR1C3
SCHEMBL3755961 0.81 APEX1 (1.00) APEX1AKR1C3
SCHEMBL3745788 0.77 APEX1 (1.00) APEX1AKR1C3HSP90AA1MAPTHTT
SCHEMBL3743461 0.77 APEX1 (1.00) APEX1AKR1C3HSP90AA1MAPTHTT
SCHEMBL3743465 0.77 APEX1 (1.00) APEX1AKR1C3HSP90AA1MAPTHTT
SCHEMBL20123270 0.76 APEX1 (0.77) APEX1AKR1C3
SCHEMBL3749264 0.70 APEX1 (1.00) APEX1AKR1C3KDM4EMAPTMAPK1
SCHEMBL3749262 0.70 APEX1 (1.00) APEX1AKR1C3KDM4EMAPTMAPK1
SCHEMBL13894618 0.69 APEX1 (0.78) APEX1AKR1C3HSP90AA1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 EP disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 APEX1 1/4885AKR1C3 933/4885KDM4E 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.